X4 Pharmaceuticals Provides Corporate Update, Including Expected Impact of COVID-19, and Reports First Quarter 2020 Financial Results
Go back to X4 Pharmaceuticals Provides Corporate Update, Including Expected Impact of COVID-19, and Reports First Quarter 2020 Financial Results| (NASDAQ: XFOR) | Delayed: 3.46 -0.05 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.51 | 52 Week High | $ | |||
| Open | $3.56 | 52 Week Low | $ | |||
| Day High | $3.59 | P/E | N/A | |||
| Day Low | $3.41 | EPS | $ | |||
| Volume | 469,882 | |||||

